US Stock MarketDetailed Quotes

BIIO BIONOVATE TECHNOLOGIES CORP

Watchlist
  • 0.000100
  • 0.0000000.00%
15min DelayClose Aug 9 16:00 ET
775.36Market Cap-20P/E (TTM)

BIONOVATE TECHNOLOGIES CORP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2021
(FY)Jun 30, 2021
(Q4)Jun 30, 2021
(Q3)Mar 31, 2021
(Q2)Dec 31, 2020
(Q1)Sep 30, 2020
(FY)Jun 30, 2020
(Q4)Jun 30, 2020
(Q3)Mar 31, 2020
(Q2)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0
0
0
0
0
0
0
0
0
0
Net income from continuing operations
5.41%-21.64K
12.70%-106.54K
14.77%-19.57K
-31.18%-31.67K
28.82%-32.43K
22.13%-22.87K
41.58%-122.05K
52.87%-22.96K
4.72%-24.14K
3.72%-45.57K
Operating gains losses
----
331.37%236
--0
78.10%-46
----
----
-134.93%-102
-99.19%1
-254.41%-210
159.12%175
Other non cash items
-96.25%144
-4.58%52.01K
57.50%6.3K
159.18%30.24K
-69.23%11.63K
265.02%3.84K
-61.49%54.5K
-88.26%4K
-9.23%11.67K
9.19%37.78K
Change In working capital
12.91%21.49K
-19.73%54.3K
-30.01%13.27K
-88.41%1.47K
169.70%20.52K
-32.96%19.03K
0.85%67.64K
30.53%18.96K
2.72%12.68K
-41.56%7.61K
-Change in payables and accrued expense
12.91%21.49K
-19.73%54.3K
-30.01%13.27K
-88.41%1.47K
169.70%20.52K
-32.96%19.03K
0.85%67.64K
30.53%18.96K
2.72%12.68K
-41.56%7.61K
Cash from discontinued investing activities
Operating cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
End cash Position
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Free cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Sep 30, 2021(FY)Jun 30, 2021(Q4)Jun 30, 2021(Q3)Mar 31, 2021(Q2)Dec 31, 2020(Q1)Sep 30, 2020(FY)Jun 30, 2020(Q4)Jun 30, 2020(Q3)Mar 31, 2020(Q2)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0000000000
Net income from continuing operations 5.41%-21.64K12.70%-106.54K14.77%-19.57K-31.18%-31.67K28.82%-32.43K22.13%-22.87K41.58%-122.05K52.87%-22.96K4.72%-24.14K3.72%-45.57K
Operating gains losses ----331.37%236--078.10%-46---------134.93%-102-99.19%1-254.41%-210159.12%175
Other non cash items -96.25%144-4.58%52.01K57.50%6.3K159.18%30.24K-69.23%11.63K265.02%3.84K-61.49%54.5K-88.26%4K-9.23%11.67K9.19%37.78K
Change In working capital 12.91%21.49K-19.73%54.3K-30.01%13.27K-88.41%1.47K169.70%20.52K-32.96%19.03K0.85%67.64K30.53%18.96K2.72%12.68K-41.56%7.61K
-Change in payables and accrued expense 12.91%21.49K-19.73%54.3K-30.01%13.27K-88.41%1.47K169.70%20.52K-32.96%19.03K0.85%67.64K30.53%18.96K2.72%12.68K-41.56%7.61K
Cash from discontinued investing activities
Operating cash flow --0--0--0--0--0--0--0--0--0--0
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position --0--0--0--0--0--0--0--0--0--0
End cash Position --0--0--0--0--0--0--0--0--0--0
Free cash flow --0--0--0--0--0--0--0--0--0--0
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg